Promising results from a Phase 1 clinical trial – Chordoma Foundation

Chordoma Foundation made the following post on X:

“Promising results have emerged from a Phase 1 clinical trial testing a new drug from Erasca called ERAS-601 alone & in combo w/ cetuximab: Nearly all of the 13 chordoma patients enrolled had some tumor shrinkage. More.”